AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 294: R510-R519, 2008. First published November 21, 2007; doi:10.1152/ajpregu.00458.2007
0363-6119/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/R510    most recent
00458.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luksha, L.
Right arrow Articles by Kublickiene, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luksha, L.
Right arrow Articles by Kublickiene, K.

DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY

Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites

Leanid Luksha,1 Henry Nisell,1 Natallia Luksha,1 Marius Kublickas,1 Kjell Hultenby,2 and Karolina Kublickiene1

1Institution for Clinical Science, Technology and Intervention, Department of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Huddinge Campus, Stockholm; and 2Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Novum, Stockholm, Sweden

Submitted 27 June 2007 ; accepted in final form 19 November 2007


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We hypothesized that in preeclampsia (PE), contribution of endothelium-derived hyperpolarizing factor (EDHF) and the mechanism/s of its action differ from that in normal pregnancy (NP). We aimed to assess endothelial function and morphology in arteries from NP and PE with particular focus on EDHF. Arteries ({approx}200 µm) were dissected from subcutaneous fat biopsies obtained from women undergoing cesarean section. With the use of wire myography, responses to the endothelium-dependent agonist bradykinin (BK) were determined before and after inhibition of pathways relevant to EDHF activity. The overall responses to BK in arteries from PE (n = 13) and NP (n = 17) were similar. However, in PE, EDHF-mediated relaxation was reduced (P < 0.05). All women within the PE group were divided into two subgroups: with more (group 1) or less (group 2) than 50% reduction of EDHF-typed responses after 18-{alpha}-glycyrrhetinic acid (an inhibitor of myoendothelial gap junctions, MEGJs). The division showed that 1) MEGJs are principally involved when the EDHF contribution is reduced; and 2) when the EDHF contribution is similar to that in NP, the H2O2 and/or cytochrome P-450 epoxygenase products of arachidonic acid (AA), along with MEGJs, confer EDHF-mediated relaxation. In contrast, MEGJs were the main pathway for EDHF in NP. The abundant presence of MEGJs in arteries from NP but deficiency of them in PE was observed using transmission electron microscopy. We conclude that PE is associated with heterogeneous contribution of EDHF, and the mechanism behind EDHF-typed responses is mediated either by MEGJs alone or in combination with H2O2 or cytochrome P-450 epoxygenase metabolites of AA.

gap junctions; small arteries; pregnancy

PREECLAMPSIA (PE) is a multisystem syndrome and remains a leading cause of maternal and perinatal morbidity and mortality. Despite intensive research, the etiology remains elusive. Indeed, opinions regarding the pathogenetic mechanism are divided. Some argue that PE is the result of inadequate trophoblast invasion in the uterine spiral arteries. This may result in placental ischemia and cause the release of placental factors with toxic effects on the maternal vascular endothelium (34). Others propose that PE is caused by an inappropriate or exaggerated maternal inflammatory response toward the presence of trophoblast debris (33).

It is generally believed that endothelial dysfunction is a hallmark of PE, and it causes many of the clinical manifestations of the disorder including hypertension, proteinuria, and edema. Studies of a variety of biochemical markers (35) and functional studies of isolated small arteries (reviewed in Ref. 26) have proposed numerous candidates and/or pathways that could potentially cause compromised endothelial function (2, 25, 39). However, none of them has yet proved to be a universal mediator or mechanism, and a combination is likely to be involved (33). Moreover, not all functional investigations have provided supportive evidence for endothelial dysfunction, and even increased responses to endothelium-dependent agonists have been observed (10). Therefore, endothelial dysfunction in PE could be vascular bed and/or agonist dependent (26), and some pathways of endothelium-dependent relaxation could be compromised when others remain preserved (18).

The role of endothelium-derived hyperpolarizing factor (EDHF) could be of interest. EDHF plays its predominant role in the resistance vasculature (26) and, as such, is ideally suited to the control of local organ blood flow, peripheral resistance, and blood pressure (30), all of which are severely disturbed in PE (46). The contribution of EDHF to enhanced endothelium-dependent relaxation in normal pregnancy has already been suggested (18, 32). Experimental evidence indicates that myoendothelial gap junctions (MEGJs) are commonly involved in EDHF-mediated responses, and this has been confirmed in arteries from the peripheral (23, 27) and the uterine (19) circulations, in which significant increases in blood flow occur in normal pregnancy (17, 36). However, functional studies of the mechanism/s mediating EDHF in PE are still lacking, and the available data pertaining to its role remain controversial and variable between the vascular bed studied and/or agonist used (20, 29, 31, 40).

We have previously reported that PE is associated with pronounced alterations in small artery endothelial morphology (42, 43), which could potentially cause impaired intercellular communication. Consequently, we hypothesized that, in arteries from women with PE, EDHF activity is mediated by one or more alternative pathways that do not require intercellular communication via MEGJs. In this study, we therefore aimed to clarify the contribution of EDHF vs. nitric oxide (NO) in bradykinin (BK)-mediated endothelium-dependent relaxation in small subcutaneous arteries from women with PE. We explored the mechanisms of EDHF-mediated responses in these arteries and examined the ultrastructure of vascular wall, paying particular attention to MEGJs.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Subjects. The study was approved by the Ethical Committee at Karolinska University Hospital, Huddinge, and all women gave informed consent before participation. PE was defined according to the criteria of the International Society for the Study of Hypertension in Pregnancy. Diagnosis required blood pressure ≥140/90 mmHg after the 20th week of gestation in association with >300 mg proteinuria in a 24-h urine collection. Exclusion criteria for both women with PE and normal pregnant (NP) women included diabetes, established atherosclerosis, chronic hypertension, malignancy, hepatic or renal failure, systemic infection, vasculitis, and recent surgery or trauma. Fifteen women with PE (6 nulliparous) with a median age of 31 yr (range 21–39 yr) and a median gestational age of 34 wk (range 31–38 wk) undergoing cesarean delivery for deterioration of PE were included. Two women with PE fulfilled the criteria for the hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome) at the time of sampling. During the operation, subcutaneous fat biopsies were collected from the incision margin and immediately placed in ice-cold physiological salt solution (PSS).

Biopsies were also obtained from 23 NP women (12 nulliparous) with a median age of 26 yr (range 18–39 yr) and a median gestational age of 38 wk (37–40 wk) undergoing planned cesarean section for indications including breach presentation (n = 8), previous cesarean section (n = 4), and psychological reasons (n = 11). In this study, some women of the NP group were also included in the NP group of our previous report about EDHF-mediated responses (27).

Experimental setup. Small subcutaneous arteries were identified and dissected from the fat biopsies by carefully removing surrounding tissue using a stereomicroscope. From each biopsy, two or more arteries of similar size, and preferably from the same vascular segment, were isolated and mounted on two stainless steel wires (25–40 µm in diameter) in the organ baths of a four-channel wire myograph (multimyograph, model no. 610; Danish Myo Technology; Aarhus, Denmark) as described previously (27). Each organ bath contained warmed (37°C) PSS and was continuously bubbled with 5% carbon dioxide in oxygen. Following a 30-min equilibration period, a passive circumference-tension curve was created for each segment to set optimum resting tension. This resting tension is calculated to simulate an in vivo transmural pressure of 100 mmHg. Arteries were then set at 90% of this tension to enable optimal contractile conditions with a low resting tension, as described previously. Calibration and data processing were performed using Myodac software (version 2.1, Danish Myo Technology) on a personal computer. All solutions were refreshed every 30 min.

Five reference constrictions were elicited. The first, second, and fifth contractions were produced using a high (124 mmol/l) potassium solution (KPSS, made by equimolar substitution of KCl for NaCl in PSS) containing 1 µmol/l norepinephrine (NE). The third was obtained with NE (1 µmol/l) alone and the fourth with KPSS alone.

Experimental protocols. All arteries were preconstricted with NE (3 µmol/l), and a concentration-response curve was obtained using incremental concentrations of BK (1 nmol/l to 3 µmol/l). Arteries were then incubated for 20 min in either PSS alone or with the nitric oxide synthase (NOS) inhibitor N{omega}-nitro-L-arginine methyl ester (L-NAME; 300 µmol/l) and the cyclooxygenase (COX) inhibitor indomethacin (Indo; 10 µmol/l) to block the production of nitric oxide (NO) and prostacyclin (PGI2), respectively. Subsequently, arteries were preconstricted again, and a second concentration-response curve for BK was obtained. The term "EDHF" used in this study refers to the L-NAME- and Indo-insensitive component of endothelium-dependent vasodilatation in response to BK. To establish whether adequate NOS inhibition was achieved with L-NAME, a concentration-response curve for BK was assessed in a separate set of arteries after incubation with L-NAME+Indo alone or in the presence of the selective guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ).

To assess whether arachidonic acid (AA) metabolites play a role in EDHF-mediated relaxation, concentration-response curves for BK were constructed in the presence of L-NAME and Indo after co-incubation with sulfaphenazole (10 µmol/l, 30 min), a specific inhibitor of cytochrome P-450 (CYP450) epoxygenase. To address the role of H2O2 in the mediation of EDHF-type responses to BK, similar experiments were performed in the presence of L-NAME and Indo with catalase (1,250 U/ml). Catalase causes the enzymatic dismutation of H2O2 to form water and oxygen. Finally, to evaluate the contribution of gap junctional communication in BK-induced EDHF-type responses, the protocols above were performed after 15-min incubation with 18-{alpha}-glycyrrhetinic acid (18-{alpha}GA; 100 µmol/l), a reversible inhibitor of gap junctional communication. We elected to use 18-{alpha}GA, despite recent debate about its specificity (7, 16), because when we previously assessed BK-induced relaxation of subcutaneous arteries from NP women, we did not find any differences between the inhibitory actions of 18-{alpha}GA and those of connexin mimetic peptides (Gap26 and Gap27, a novel group of selective and reversible gap junction inhibitors) (23, 27).

In separate experiments, concentration-response curves for NO donor sodium nitroprusside (SNP) and ATP-sensitive potassium channel opener pinacidil (10 nmol/l to 100 µmol/l) were evaluated before and after incubation with inhibitors used in arteries from NP women.

Transmission electron microscopy. Artery segments were fixed in 2% glutaraldehyde + 0.5% paraformaldehyde in 0.1 M sodium cacodylate buffer containing 0.1 M sucrose and 3 mM CaCl2, pH 7.4, at room temperature for 30 min followed by 24 h at 4°C. Specimens were rinsed in 0.15 M sodium cacodylate buffer containing 3 mM CaCl2, pH 7.4; postfixed in 2% osmium tetroxide in 0.07 M sodium cacodylate buffer containing 1.5 mM CaCl2, pH 7.4, at 4°C for 2 h; and dehydrated in ethanol followed by acetone and embedded in LX-112 (Ladd, Burlington, VT). Semi-thin sections were cut and stained with toludin blue and used for light microscopic analysis. Ultra-thin sections (~40–50 nm) were contrasted with uranyl acetate followed by lead citrate (14). Sections were examined in a Tecnai 10 transmission electron microscope at 80 kV, and digital images were captured by a Mega View III digital camera (Soft Imaging System, Muenster, Germany).

Chemicals. The composition of PSS was as follows (in mmol/l): NaCl 119, KCl 4.7, CaCl2 2.5, MgSO4 1.17, NaHCO3 25, KH2PO4 1.18, EDTA 0.026, and glucose 5.5. The chemicals were obtained from Sigma (St. Louis, MO). To prepare stock solution, the substances were dissolved in distilled water. Indo, pinacidil, and U46619 [GenBank] were dissolved in ethanol. All concentrations represent the final steady-state concentrations in the chamber. Pilot studies showed that the solvent used has no effect on the mechanical responses at their final bath concentrations.

Data analysis. The force developed per millimeter of artery segment during application of each concentration of vasoactive compound was calculated using Myodata (Danish Myo Technology). Data were then transferred to STATISTICA (version 7.0; StatSoft, Uppsala, Sweden), in which all statistical analyses were performed. All absolute measurements were corrected for the baseline force developed by the arteries. The relaxation response to BK was calculated as a percentage of the contraction. Negative log concentration required to cause 50% of the maximum response (pEC50) was calculated by nonlinear regression analysis. ANOVA was used to compare concentration-response curves before and after incubation with different pharmacological inhibitors. Paired and unpaired Student's t-tests, as appropriate, were used to compare pEC50 before and after incubation with different agents in arteries used in different experimental protocols. The number and length (µm) of protrusions per section, thickness of internal elastic lamina (IEL; µm), and percentage of the area with detached endothelium from the basement membrane were compared among arteries from PE and NP groups. All data are presented as means ± SE unless indicated in the text; n represents the number of patients. Significance was taken at the 5% level for all comparisons.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
In total, 44 arteries with an internal diameter of 219 ± 11 µm were dissected from 15 biopsies from women with PE, and 74 arteries with internal diameter of 244 ± 15 µm were dissected from 23 biopsies from NP women. There was no difference in internal diameter, the magnitude of contraction in response to KPSS (2.6 ± 0.2 mN/mm in PE vs. 2.8 ± 0.2 mN/mm in NP), or the preconstriction level with NE (2.6 ± 0.2 in PE vs. 3.2 ± 0.2 mN/mm in NP) among the arteries used for different experimental protocols.

Arteries from NP women relaxed in response to increasing concentrations of BK up to 85–95%. The concentration-response curves for BK were similar before and after a 30-min incubation in PSS alone, indicating that BK-mediated dilatation was reproducible (pEC50: 7.4 ± 0.2 first vs. 7.7 ± 0.2 second concentration-response curve, n = 5).

Concentration-response curves for BK in PSS were similar between arteries from PE and NP (pEC50: 7.3 ± 0.1 vs. 7.4 ± 0.1, P > 0.05, ANOVA; Fig. 1). In arteries from both groups, incubation with L-NAME+Indo resulted in a significant reduction in relaxation in response to BK compared with that obtained with PSS (P < 0.05, ANOVA; Fig. 1). This suggests that the NO/prostanoid-independent component (i.e., mediated by EDHF) contributes significantly to BK-induced relaxation in isolated arteries from women with PE and NP (up to 60% of the total BK response). This overall reduction was, however, more pronounced in PE arteries compared with NP arteries [%relaxation in response to BK at 3 µmol/l (here and below): 51 ± 2.0 for PE vs. 60 ± 4 for NP, P < 0.05, ANOVA; Fig. 1], although there was no difference in pEC50 between these arteries (6.8 ± 0.1 for PE vs. 7.0 ± 0.1 for NP). Thus the contribution of EDHF- rather than NO-mediated relaxation appeared to be compromised in arteries from women with PE.


Figure 1
View larger version (26K):
[in this window]
[in a new window]

  		Fig. 1. Concentration-response curves for bradykinin (BK) in isolated subcutaneous arteries from normal pregnant (NP) and preeclamptic (PE) women in physiological salt solution (PSS) and after incubation with N{omega}-nitro-L-arginine methyl ester in combination with indomethacin (L-NAME+Indo). *P < 0.05, PE vs. NP.

 
Contribution of MEGJs to EDHF-mediated relaxation in PE. While MEGJs are the major component of EDHF-mediated responses in arteries from NP women [19 ± 3% L-NAME+Indo+18-{alpha}GA (n = 9) vs. 65 ± 8% L-NAME+Indo (n = 9), P < 0.001; Fig. 2A], in PE we found heterogeneity in the ability of 18-{alpha}GA to influence the EDHF-mediated component of the response to BK. On the basis of that, we divided the PE group into two subgroups. In one subgroup (PE-1), composed of seven women with PE, incubation of arteries with 18-{alpha}GA produced a substantial reduction in BK-mediated dilatation (i.e., >50% reduction of BK-induced relaxation compared with relaxation after incubation with L-NAME+Indo), and it was comparable with the response seen in arteries from NP women (15 ± 3% for PE vs. 19 ± 3% for NP; Fig. 2A), suggesting an important role of MEGJs. In the second subgroup (PE-2), composed of the remaining women with PE (n = 5), arteries responded differently, and incubation with 18-{alpha}GA had a small (i.e., <50% reduction of BK-induced relaxation compared with relaxation after incubation with L-NAME+Indo) but still significant (57 ± 5% L-NAME+ Indo+18-{alpha}GA vs. 67 ± 4% L-NAME+Indo, P < 0.05; Fig. 2B) influence on EDHF-mediated relaxation. The smaller effect of 18-{alpha}GA in the PE-2 subgroup suggests that another pathway, in addition to MEGJs, may be active in mediating EDHF. As reflected in Fig. 3, the difference between the subgroups was not only limited to the mechanism of EDHF-mediated relaxation. The contribution of EDHF to total relaxation was also significantly greater in PE-2 vs. PE-1 (67 ± 4 vs. 45 ± 6%, respectively, P < 0.05), although pEC50 was not different between arteries from the two subgroups (7.0 ± 0.2 for PE-2 vs. 6.9 ± 0.1 for PE-1).


Figure 2
View larger version (24K):
[in this window]
[in a new window]

  		Fig. 2. Concentration-response curves for BK in isolated subcutaneous arteries from NP and PE women after incubation with L-NAME+Indo alone or in combination with 18{alpha}-glycyrrhetinic acid (L-NAME+Indo+18{alpha}-GA). A: comparison between arteries from NP and PE [i.e., arteries that demonstrate a substantial reduction of endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation by 18{alpha}-GA]. B: comparison between arteries from NP and PE (i.e., arteries that demonstrate a minor reduction of EDHF-mediated relaxation by 18{alpha}-GA). *P < 0.05, PE (L-NAME+Indo) vs. NP (L-NAME+Indo); #P < 0.05, PE (L-NAME+Indo) vs. PE (18{alpha}-GA+L-NAME+Indo); &P < 0.05, NP (L-NAME+Indo) vs. NP (18{alpha}-GA+L-NAME+Indo); §P < 0.05, PE (18{alpha}-GA+ L-NAME+Indo) vs. NP (18{alpha}-GA+L-NAME+Indo).

 

Figure 3
View larger version (26K):
[in this window]
[in a new window]

  		Fig. 3. A heterogeneous contribution of EDHF (after incubation with L-NAME+Indo) to BK-induced relaxation in arteries from women with PE. PE-1 group, arteries that demonstrated a substantial reduction of EDHF-mediated relaxation by 18{alpha}-GA; PE-2 group, arteries that demonstrated a minor reduction of EDHF-mediated relaxation by 18{alpha}-GA. *P < 0.05, PE-1 vs. PE-2.

 
Thus the similar BK-induced relaxation in PSS and the variability in responses after incubation with L-NAME+Indo strongly suggest that women with PE in this study differed in terms of the relative contributions made by EDHF and NO toward overall endothelium-dependent relaxation in isolated arteries. Moreover, among the women with PE and with reduced EDHF contribution (PE-1), MEGJs seemed to be the main mechanism responsible for EDHF activity. On the other hand, in women with PE in whom EDHF made a larger contribution (similar magnitude to that seen in NP women, PE-2), MEGJs were involved to a lesser extent, and one or more additional or alternative mechanisms appeared to predominate.

Contribution of endogenous H2O2 and arachidonic acid metabolites to EDHF-mediated relaxation in PE. The contribution of endogenous H2O2 to EDHF-mediated relaxation was evaluated in 12 women with PE. Catalase significantly attenuated the response to BK after NOS and COX inhibition in arteries from three women, all from the PE-2 subgroup (Fig. 4A). After incubation with catalase, responses to BK were significantly different between arteries from the PE-2 subgroup (n = 3) and those from the NP group (25 ± 6 vs. 47 ± 5, P < 0.05; Fig. 4A). In arteries from the rest of the women with PE (n = 9), catalase failed to attenuate the EDHF-mediated response [pEC50: 6.6 ± 0.1 after vs. 6.7 ± 0.1 before incubation with catalase (n = 9), P > 0.5; Fig. 4B], and relaxation in response to BK after incubation with catalase was similar in arteries from PE and NP women [pEC50: 6.6 ± 0.1 (n = 9) vs. 6.7 ± 0.2 (n = 12), P > 0.5].


Figure 4
View larger version (25K):
[in this window]
[in a new window]

  		Fig. 4. Concentration-response curves for BK in isolated subcutaneous arteries from NP and PE groups and the PE-2 subgroup after incubation with L-NAME+Indo and in combination with catalase. A: EDHF-mediated responses between arteries from NP women and women from PE-2 group. B: EDHF-mediated responses between arteries from PE-2 vs. PE group (arteries from the rest of the women with PE, where catalase failed to reduce EDHF-mediated response). *P < 0.05, PE-2 (L-NAME+Indo) vs. PE (L-NAME+Indo); #P < 0.05, PE (L-NAME+Indo) vs. PE (catalase+L-NAME+Indo); &P < 0.05, NP (L-NAME+Indo) vs. NP (catalase+L-NAME+Indo); §P < 0.05, PE-2 (catalase+L-NAME+Indo) vs. NP (catalase+L-NAME+Indo).

 
The mechanism of EDHF-mediated relaxation in subcutaneous arteries from the last two women of the PE-2 subgroup involved the metabolite of CYP450 epoxygenase, presumably epoxyeicosatrienoic acids (EETs). Simultaneous incubation with L-NAME+Indo and sulfaphenazole markedly attenuated BK-induced relaxation by up to 23% (Fig. 5A). In contrast, in arteries from other women with PE (3 from PE-2 and 5 from PE-1), sulfaphenazole did not affect the EDHF-mediated relaxation, and concentration-response curves for BK were similar in arteries after incubation with L-NAME+Indo vs. L-NAME+Indo+sulfaphenazole [pEC50: 6.9 ± 0.1 vs. 6.8 ± 0.1 (n = 8), P > 0.5; Fig. 5B] and were also similar in arteries from NP women [pEC50: 6.8 ± 0.2 vs. 6.7 ± 0.2 (n = 6); Fig. 5C].


Figure 5
View larger version (15K):
[in this window]
[in a new window]

  		Fig. 5. Concentration-response curves for BK in isolated subcutaneous arteries from NP, PE, and PE-2 after incubation with L-NAME+Indo in combination with sulfaphenazole (Sulf+L-NAME+Indo; 30 min). A: EDHF-mediated responses in arteries from PE-2. B: EDHF-mediated responses in arteries from PE (arteries from the rest of the women with PE, where sulfaphenazole failed to reduce EDHF-mediated response). C: EDHF-mediated responses in arteries from NP.

 
Thus, in addition to MEGJs, endothelial H2O2 and CYP450 epoxygenase metabolites of AA were involved in EDHF-mediated relaxation of small subcutaneous arteries from women in the PE-2 subgroup. This is in contrast to NP, where MEGJs appeared to be the main mechanism responsible for EDHF-mediated relaxation of subcutaneous arteries. Subgroup analysis was performed with respect to the demographic characteristics of the women with PE and included pregnancy history, age, parity, gestational age, birth weight, and blood pressure. However, this did not yield any helpful information for interpreting the basis of the observed functional heterogeneity in the pathways involved in EDHF-mediated relaxation.

Specificity of the inhibitors. Sulfaphenazole (10 µmol/l) or catalase (1,250 U/ml) in PSS did not affect the vasodilator responses to both SNP and pinacidil (Table 1).


View this table:
[in this window]
[in a new window]

  		Table 1. Sensitivity and relaxation to highest concentration of SNP and PIN before and after incubation with inhibitors of pathways relevant for EDHF-typed responses

 
Because of our previously reported observation that incubation with 18{alpha}-GA alone but not in combination with L-NAME+Indo significantly reduced NE-induced tone (27), all specificity experiments for 18{alpha}-GA were performed after preincubation of arteries with L-NAME+Indo. Similar responses to SNP and pinacidil after incubation with L-NAME+Indo vs. L-NAME+Indo+18{alpha}-GA led us to suggest that the inhibitory effect of 18{alpha}-GA at the concentration used in the present study on BK-induced relaxation is mostly due to its specific action on gap junctions.

Incubation with L-NAME, the NOS inhibitor, was sufficient to block NO generation, as dilatation to BK was not further reduced by ODQ (pEC50: 7.0 ± 0.1 vs. 6.8 ± 0.2, n = 4).

Transmission electron microscopy. Arteries used for morphological evaluation had an internal diameter that was the same as arteries used for functional studies in NP women and women with PE. The morphological prerequisites taken to be indicative of the presence of gap junctions between endothelial cells (ECs) and smooth muscle cells (SMCs) in arteries from PE (n = 4) and NP women (n = 4) were obtained using transmission electron microscopy, and the images are presented in Figs. 6 and 7.


Figure 6
View larger version (83K):
[in this window]
[in a new window]

  		Fig. 6. Transmission electron micrographs of human subcutaneous arteries from NP. Pictures show the ultrastructure of the vascular wall with particular focus on the close intercellular contacts between the cells within the wall (A–D and I). Low-magnification pictures show an overview of the vascular wall with endothelial cells (ECs) and vascular smooth muscle cells (SMCs) separated by the internal elastic lamina (IEL), which has penetrations allowing protrusions from both ECs and SMCs to meet with each other. ECs sent a large no. of long projections (see A; up to 6.5 µm, brace and arrows) toward SMCs. Areas denoted by boxes are magnified and show the close contact between the cells. F–H and J: protrusions from both ECs and SMCs in tight association with each other are considered as prerequisites for myoendothelial gap junction (MEGJ). The width of the gap is ~10 nm (F and G; arrows), ~12 nm (H; arrow), and ~13 nm (J; arrows). Bar: A, 5 µm; B and C, 2 µm; D and J, 1 µm; E, 0.3 µm; G and H, 100 nm; I, 3 µm.

 

Figure 7
View larger version (98K):
[in this window]
[in a new window]

  		Fig. 7. Transmission electron micrographs of human subcutaneous arteries from pregnant women with PE (A–E). The low-magnification pictures show an overview of vascular wall with ECs and SMCs separated by IEL. The thickness of IEL is irregular and nonhomogenous (B) and contains relatively more collagen-like fibers (A, B, and D; asterisks). Many vacuoles are observed in the intima, and there are also many areas with detached endothelium from the basement membrane (B, D, and E; arrowheads). The endothelium becomes very thin in some places (C). Long projections of SMCs rather than ECs are observed (C; arrow up to 1.5 µm). Occasionally, contacts between ECs and SMCs are observed (A, C, F, and G) that concur with functional findings, supporting a contribution of gap junctions in EDHF-mediated responses in some women with PE. The areas denoted by the boxes are magnified and show the close contact between the ECs and SMCs (F and G). The width of the gap is ~10–12 nm (G; arrows) and ~10 nm (C; arrows). Bar: A, 3 µm; B and F, 2 µm; C, 1 µm; D, 5 µm; E, 4 µm; G, 0.1 µm.

 
Ultrastructural micrographs of arteries from NP women indicated a relatively large number (40 ± 14 per artery section) of long protrusions (3.8 ± 0.9 µm), mainly from ECs (Fig. 6, A–D). These protrusions were observed penetrating the relatively large IEL (3.5 ± 0.7 µm) to form close contacts between ECs and SMCs within the vascular wall (Fig. 6, F–J). This type of contact previously referred to pentalaminar structures (13) considered to be prerequisite for MEGJs (Fig. 6, F–H).

In arteries from women with PE, the morphology contrasted with that seen in arteries from NP women and suggested an obstruction to the formation of intercellular contacts (Fig. 7). The percentage of the area with detached endothelium from the basement membrane was 25 ± 8% in PE (Fig. 7, B–E) vs. 4 ± 1.8% in NP (P < 0.05). In arteries from women with PE, the thickness of IEL had a tendency to be enhanced compared with controls (5.1 ± 0.6 vs. 3.5 ± 0.7 µm, P = 0.08), probably because of an increased presence of collagen-like fibers (Fig. 7, B–D), and there were alterations in the size and shape of the ECs themselves (the thinned part of ECs: 0.3 ± 0.1 µm in PE vs. 1.4 ± 0.6 µm in NP, P < 0.05). In one of four preparations from the PE group, only sporadic and short protrusions of ECs (0.6 ± 0.2 µm) were observed in the PE (Fig. 7C) compared with the NP group (3.8 ± 0.9 µm, P < 0.05). In the PE group, rather than the ECs extending protrusions, it was the SMCs that sent out relatively long protrusions (up to 1.5 µm; Fig. 7C) to establish contacts with ECs.


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
This study shows that, in terms of sensitivity and magnitude, the overall endothelium-dependent response to BK in small subcutaneous arteries from women with PE is similar to that seen in NP women. However, in PE the component of endothelium-dependent relaxation insensitive to NOS and COX inhibition (i.e., EDHF) is reduced. Our results suggest heterogeneity in the relative contribution of endothelium-derived factors involved in BK-induced relaxation and in the mechanisms responsible for the EDHF-mediated component in PE. MEGJs and/or H2O2 and/or CYP450 epoxygenase metabolites of AA appear to be involved in the EDHF-mediated response in PE, while in NP women, communication via MEGJs seems to be the common pathway responsible for EDHF action.

In PE, impaired relaxations in response to both ACh (29) and BK (20) have been reported in the same vascular beds. These are not universal findings, as abolished ACh-mediated dilatation but preserved relaxation to substance P (47) or similar responses to ACh and BK in NP and women with PE (46) have been reported by others. Our finding is in line with those reporting similar overall responses in NP and women with PE. However, it contrasts with one study (20), in which comparable protocols were used to examine arteries from one-half as many women with PE as examined here (20). Inconsistent responses to endothelium-dependent agonists in PE have also been reported in other vascular beds including omental and myometrial arteries (3, 18, 31, 40), and these divergent results are likely to result from heterogeneity of endothelial dysfunction in PE or may reflect the different agonists and methods employed.

The pathways involved in compromised endothelial function in PE have been suggested previously. McCarthy et al. (29) addressed reduced ACh-induced relaxation in response to the attenuated PGI2-mediated component. However, changes in NO- and EDHF-mediated responses have been suggested to confer blunted relaxation in response to BK (20). Our study argues that it is the EDHF- rather than the NO-mediated component of BK-mediated relaxation that is compromised in PE. Indeed, a difference in BK-mediated dilatation was observed between PE and NP only after the inhibition of NOS and COX products. Our results concur with one study in small myometrial arteries (18), in which BK evoked similar overall vasorelaxant responses in NP women and women with PE, but the EDHF-mediated component of relaxation was impaired in the arteries from women with PE.

Although the role of MEGJs in EDHF-mediated responses in NP women has been repeatedly confirmed, not only in subcutaneous (23, 27) but also in other vascular beds (19), to our knowledge, we are the first to report the mechanism/s behind EDHF-mediated relaxation in PE. Our study further strengthens the increasingly accepted hypothesis that a single factor or mechanism acting as a "universal" EDHF does not exist (26). Accordingly, its identity or mechanism may vary depending on the species or type of artery examined. Furthermore, as exemplified in our study, its identity may be altered in the diseased state, and there is further evidence to support this. For example, dyslipidemia may duplicate the mechanisms responsible for EDHF-induced dilatation in small arteries of mice (22); although it has been demonstrated that CYP450 AA metabolites can account for EDHF activity in healthy nonpregnant volunteers (8), their involvement has not been confirmed in the same vascular bed in patients with cancer or cardiovascular disease (5).

In this study, we have shown that heterogeneous EDHF pathways exist in PE. We also identified mechanisms for EDHF activity that may either be alternative to or complementary to a requirement for MEGJs in EDHF-mediated relaxation in this disorder. The PE group was divided into two subgroups stratified by the magnitude of the inhibition of EDHF achieved by an antagonist of gap junction-mediated communication. This suggested that ~60% of patients with PE in this investigation had a reduced contribution of EDHF to endothelium-dependent relaxation, and, in this subgroup (PE-1), communication via MEGJs was preserved as a central mechanism for the EDHF-mediated response. However, it should be noted that we did not achieve a 100% abolishment of EDHF-typed responses after incubation with 18-{alpha}GA in arteries from NP women as well as in the PE-1 group. One explanation could be that the concentration of 18{alpha}-GA used was not high enough to block completely gap junctions, and we intentionally did not use a higher concentration to minimize unspecific effects of the inhibitor suggested by others (9). There is also a theoretical possibility that another pathway could be involved along with MEGJ, although the latter plays a primary role.

In contrast, in arteries from the other PE subgroup (PE-2), EDHF made a contribution to BK-induced relaxation similar to that seen in NP. However, in this PE subgroup, MEGJs appeared to play a minor role, and H2O2 and CYP450 metabolites of AA appeared as alternative and/or additional candidates for EDHF-mediated relaxation in subcutaneous arteries. Although the reasons behind these disparities remain unknown and warrant further investigation, it is possible that the similar contribution of EDHF to BK-induced relaxation in NP and in some PE women is maintained because of additional pathways (e.g., H2O2 or CYP450 metabolites of AA) invoked to compensate for the compromised MEGJ-mediated EDHF component of relaxation. Indeed, there is some evidence that H2O2 and CYP450 metabolites of AA might serve to control vascular tone in PE. The oxidative stress associated with PE (37) may influence the production of H2O2, which can act as an inhibitor of gap junctions itself (45) or, if produced in ECs, can influence vascular tone (28). The increased urinary excretion of EETs has also been reported in pregnant women with hypertension (6).

Ultrastructural analysis of the vascular wall indicated various differences between arteries from NP women and women with PE. In arteries from NP women, the regular projections sent from ECs through the IEL toward SMCs represent areas in which MEGJs are typically found. Classically, in transmission electron micrographs, gap junctions appear as pentalaminar-like structures at points of close membrane apposition (13). We believe that we have shown close associations between ECs and SMCs (see Fig. 6, E–H) and that these represent typical MEGJs. However, at this level, the junctional membranes could be less closely apposed as a result of either oblique visualization or a lack of organized gap junctional plaques. Indeed, it has been suggested that only individual gap junctional channels rather than gap junctional plaques provide the pathway for EC-SMC communication at the MEGJ (13). In contrast, deficiency of pentalaminar-like structures was confirmed in vessels from women with PE, and communications between ECs and SMCs were impaired, probably because of a number of changes observed in the vascular wall that could cause an obstacle to the establishment of tight interactions between ECs and SMCs. Those changes primarily included alterations in the morphology and size of ECs themselves (see Fig. 7, C and D) accompanied by an apparent deficiency of projections toward SMCs (see Fig. 7, B and E). Overall, these findings concur with our previous report demonstrating endothelial abnormalities in PE, confirmed by use of scanning microscopy in subcutaneous (42) and myometrial (43) arteries. Similar changes in EC morphology have also been reported in umbilical (48), fetal villous (11), and omental (41) arteries obtained from women with PE.

It could be suggested that the ultrastructural and functional abnormalities that develop in small arteries during PE may confer a vascular phenotype that predisposes one to the development of cardiovascular disorders later in life. This is reflected in several studies examining women with a history of NP vs. women who have had a pregnancy complicated by PE (1, 4, 15). Endothelial repair by the recruitment of endothelial progenitor cells or by the replication of neighboring ECs is associated with normalization of some, but not all, aspects of endothelial function (12). In those areas that are repaired, the disturbances in endothelium-dependent relaxation may be critically dependent on the upregulation of EDHF-mediated vasodilatation to preserve overall endothelium-dependent dilatation (21, 24, 38, 44).

In summary, we have demonstrated that PE is associated with apparent functional and morphological differences in small peripheral arteries. Although the overall endothelium-dependent response to BK was preserved in PE, the contribution of EDHF to relaxation is significantly reduced and heterogeneous. In PE the mechanism of EDHF-typed responses is mediated either by MEGJs alone or in combination with H2O2 or CYP450 epoxygenase metabolites of AA. We have suggested that the morphological alterations within the vascular wall may underlie the diminished contribution that MEGJs make in the mediation of EDHF vasorelaxation in PE. The clear heterogeneity in the contribution of EDHF to endothelium-dependent relaxation and its dynamic nature provides an intriguing challenge for further investigations, which need to be performed in other vascular beds from women with PE and women of reproductive age with a prior history of PE.


   GRANTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by grants from the Swedish Heart and Lung Foundation, Center of Gender-Related Medicine at Karolinska Institutet, the Swedish Society of Medicine, and Anders Otto Swärds and Lars Hiertas Minne Foundations.


   ACKNOWLEDGMENTS
 
We are grateful to Dr. Ninian N. Lang for critical reading of the manuscript.


   FOOTNOTES
 

Address for reprint requests and other correspondence: K. Kublickiene, Institution for Clinical Science, Intervention and Technology (CLINTEC), Dept. of Obstetrics and Gynecology, Karolinska Institute, Karolinska Univ. Hospital-Huddinge Campus, 14186 Stockholm, Sweden (e-mail: karolina.kublickiene{at}ki.se)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 286: H1389–H1393, 2004.[Abstract/Free Full Text]
  2. Ajne G, Wolff K, Fyhrquist F, Carlstrom K, Hemsen-Mortberg A, Nisell H. Endothelin converting enzyme (ECE) activity in normal pregnancy and preeclampsia. Hypertens Pregnancy 22: 215–224, 2003.[CrossRef][Web of Science][Medline]
  3. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 104: 1152–1158, 1997.[Web of Science][Medline]
  4. Blaauw J, van Pampus MG, Van Doormaal JJ, Fokkema MR, Fidler V, Smit AJ, Aarnoudse JG. Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol 107: 1345–1351, 2006.[CrossRef][Web of Science][Medline]
  5. Buus NH, Simonsen U, Pilegaard HK, Mulvany MJ. Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 129: 184–192, 2000.[CrossRef][Web of Science][Medline]
  6. Catella F, Lawson JA, Fitzgerald DJ, FitzGerald GA. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci USA 87: 5893–5897, 1990.[Abstract/Free Full Text]
  7. Chaytor AT, Marsh WL, Hutcheson IR, Griffith TM. Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium 7: 265–278, 2000.[Web of Science][Medline]
  8. Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C. Endothelium-derived hyperpolarizing factor: identification and mechanisms of action in human subcutaneous resistance arteries. Circulation 103: 1702–1708, 2001.[Abstract/Free Full Text]
  9. Coleman HA, Tare M, Parkington HC. K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat, and human blood vessels. J Physiol 531: 359–373, 2001.[Abstract/Free Full Text]
  10. Davis KR, Ponnampalam J, Hayman R, Baker PN, Arulkumaran S, Donnelly R. Microvascular vasodilator response to acetylcholine is increased in women with pre-eclampsia. BJOG 108: 610–614, 2001.[CrossRef][Medline]
  11. de Luca Brunori I, Battini L, Brunori E, Lenzi P, Paparelli A, Simonelli M, Valentino V, Genazzani AR. Placental barrier breakage in preeclampsia: ultrastructural evidence. Eur J Obstet Gynecol Reprod Biol 118: 182–189, 2005.[CrossRef][Web of Science][Medline]
  12. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985–H1002, 2006.[Abstract/Free Full Text]
  13. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology 19: 277–284, 2004.[Abstract/Free Full Text]
  14. Forster C, Kietz S, Hultenby K, Warner M, Gustafsson JA. Characterization of the ERβ–/– mouse heart. Proc Natl Acad Sci USA 101: 14234–14239, 2004.[Abstract/Free Full Text]
  15. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, Price K, Karumanchi SA, Valdes G. Endothelial dysfunction: link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49: 90–95, 2007.[Abstract/Free Full Text]
  16. Goto K, Fujii K, Kansui Y, Abe I, Iida M. Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries. Clin Exp Pharmacol Physiol 29: 595–602, 2002.[CrossRef][Web of Science][Medline]
  17. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9: 147–160, 2002.[CrossRef][Web of Science][Medline]
  18. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci (Lond) 103: 67–73, 2002.[Medline]
  19. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br J Pharmacol 136: 1085–1088, 2002.[CrossRef][Web of Science][Medline]
  20. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 175: 1668–1674, 1996.[CrossRef][Web of Science][Medline]
  21. Kohler R, Brakemeier S, Kuhn M, Behrens C, Real R, Degenhardt C, Orzechowski HD, Pries AR, Paul M, Hoyer J. Impaired hyperpolarization in regenerated endothelium after balloon catheter injury. Circ Res 89: 174–179, 2001.[Abstract/Free Full Text]
  22. Krummen S, Falck JR, Thorin E. Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice. Br J Pharmacol 145: 264–270, 2005.[CrossRef][Web of Science][Medline]
  23. Lang NN, Luksha L, Newby D, Kublickiene K. Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women. Am J Physiol Heart Circ Physiol 292: H1026–H1032, 2007.[Abstract/Free Full Text]
  24. Lippolis L, Sorrentino R, Popolo A, Maffia P, Nasti C, d'Emmanuele di Villa Bianca R, Marzocco S, Autore G, Pinto A. Time course of vascular reactivity to contracting and relaxing agents after endothelial denudation by balloon angioplasty in rat carotid artery. Atherosclerosis 171: 171–179, 2003.[CrossRef][Web of Science][Medline]
  25. Liu HS, Chu TY, Yu MH, Chang YK, Ko CS, Chao CF. Thromboxane and prostacyclin in maternal and fetal circulation in pre-eclampsia. Int J Gynecol Obstet 63: 1–6, 1998.[CrossRef][Medline]
  26. Luksha L, Kublickiene K. Implications for endothelium-derived hyperpolarizing factor (EDHF) in women's cardiovascular health. Curr Women Health Rev 1: 67–78, 2005.[CrossRef]
  27. Luksha L, Nisell H, Kublickiene K. The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women. Am J Physiol Regul Integr Comp Physiol 286: R1102–R1109, 2004.[Abstract/Free Full Text]
  28. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909–913, 2002.[CrossRef][Web of Science][Medline]
  29. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 168: 1323–1330, 1993.[Web of Science][Medline]
  30. Mulvany MJ. Structure and function of small arteries. Physiol Rev 70: 921–961, 1990.[Abstract/Free Full Text]
  31. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 101: 464–470, 1998.[Web of Science][Medline]
  32. Pascoal IF, Umans JG. Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension 28: 183–187, 1996.[Abstract/Free Full Text]
  33. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 308: 1592–1594, 2005.[Abstract/Free Full Text]
  34. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46: 1243–1249, 2005.[Abstract/Free Full Text]
  35. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23: 359–372, 2002.[CrossRef][Web of Science][Medline]
  36. Robson S. Maternal respiratory and cardiovascular changes during pregnancy. In: Scientific Essentials of Reproductive Medicine, edited by Hillier SG, Kitchener HC, and Neilson JP. Philadelphia, PA: Saunders, 1996, p. 443–454.
  37. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 8: 1–20, 2006.[Medline]
  38. Shimokawa H, Flavahan N, Vanhoutte P. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 65: 740–753, 1989.[Abstract/Free Full Text]
  39. Suzuki Y, Hattori T, Kajikuri J, Yamamoto T, Suzumori K, Itoh T. Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia. J Physiol 545: 269–277, 2002.[Abstract/Free Full Text]
  40. Suzuki Y, Kajikuri J, Suzumori K, Itoh T. Mechanisms underlying the reduced endothelium-dependent relaxation in human omental resistance artery in pre-eclampsia. J Physiol 527: 163–174, 2000.[Abstract/Free Full Text]
  41. Suzuki Y, Yamamoto T, Mabuchi Y, Tada T, Suzumori K, Soji T, Herbert DC, Itoh T. Ultrastructural changes in omental resistance artery in women with preeclampsia. Am J Obstet Gynecol 189: 216–221, 2003.[CrossRef][Web of Science][Medline]
  42. Svedas E, Islam KB, Nisell H, Kublickiene KR. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol 188: 168–176, 2003.[CrossRef][Web of Science][Medline]
  43. Svedas E, Nisell H, Vanwijk MJ, Nikas Y, Kublickiene KR. Endothelial dysfunction in uterine circulation in preeclampsia: can estrogens improve it? Am J Obstet Gynecol 187: 1608–1616, 2002.[CrossRef][Web of Science][Medline]
  44. Thollon C, Bidouard JP, Cambarrat C, Delescluse I, Villeneuve N, Vanhoutte PM, Vilaine JP. Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium. Circ Res 84: 371–377, 1999.[Abstract/Free Full Text]
  45. Todt I, Ngezahayo A, Ernst A, Kolb HA. Hydrogen peroxide inhibits gap junctional coupling and modulates intracellular free calcium in cochlear Hensen cells. J Membr Biol 181: 107–114, 2001.[Web of Science][Medline]
  46. VanWijk MJ, Boer K, van der Meulen ET, Bleker OP, Spaan JA, VanBavel E. Resistance artery smooth muscle function in pregnancy and preeclampsia. Am J Obstet Gynecol 186: 148–154, 2002.[CrossRef][Web of Science][Medline]
  47. Wimalasundera RC, Thom SA, Regan L, Hughes AD. Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman. Am J Obstet Gynecol 192: 625–632, 2005.[CrossRef][Web of Science][Medline]
  48. Yulug E, Yenilmez E, Unsal M, Aydin S, Tekelioglu Y, Arvas H. Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia. Acta Obstet Gynecol Scand 85: 1038–1045, 2006.[Web of Science][Medline]



This article has been cited by other articles:


Home page
 StrokeHome page
M. J. Cipolla, J. Smith, M. M. Kohlmeyer, and J. A. Godfrey
SKCa and IKCa Channels, Myogenic Tone, and Vasodilator Responses in Middle Cerebral Arteries and Parenchymal Arterioles: Effect of Ischemia and Reperfusion
Stroke, April 1, 2009; 40(4): 1451 - 1457.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/R510    most recent
00458.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luksha, L.
Right arrow Articles by Kublickiene, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luksha, L.
Right arrow Articles by Kublickiene, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.